Positive Association Between Serum Resistin and Smoking Was Strongest in Homozygotes of the G-A Haplotype at C.-420 C>G and C.-358 G>A in RETN Promoter: the Toon Genome Study
Overview
Authors
Affiliations
Resistin is mainly expressed in human monocytes/macrophages and is associated with insulin resistance, inflammation, and atherosclerosis. Serum resistin is strongly correlated with the G-A haplotype defined by single nucleotide polymorphisms (SNPs) c.-420 C>G (SNP-420) (rs1862513) and c.-358 G>A (SNP-358) (rs3219175) in the promoter region of the human resistin gene (RETN). Smoking is also associated with insulin resistance. We investigated the association between smoking and serum resistin and the effect of the G-A haplotype on this association. Participants were recruited under the Toon Genome Study (an observational epidemiology research in the Japanese population). Of these, 1975 subjects genotyped for both SNP-420 and SNP-358 were analyzed for serum resistin by grouping them based on smoking status and G-A haplotype status. RETN mRNA, isolated from whole blood cells, was evaluated in smokers (n = 7) and age-, sex-, and BMI-matched non-smokers (n = 7) with the G-A haplotype homozygotes. Serum resistin tended to be higher in current smokers who smoked more cigarettes per day (P for trend < 0.0001). The positive association between serum resistin and smoking was strongest in the G-A haplotype homozygotes, followed by heterozygotes and non-carriers (interaction P < 0.0001). This positive association was stronger in the G-A homozygotes than the C-G homozygotes (interaction P < 0.0001). RETN mRNA was 1.40-fold higher in smokers than non-smokers with the G-A homozygotes (P = 0.022). Therefore, the positive association between serum resistin and smoking was strongest in the G-A haplotype homozygotes defined by RETN SNP-420 and SNP-358.
Rachwalik M, Sarelo P, Obremska M, Matusiewicz M, Sett K, Czapla M Front Public Health. 2024; 12:1484195.
PMID: 39635208 PMC: 11614759. DOI: 10.3389/fpubh.2024.1484195.
Wu Z, Liu S, Yang Z, Meng X, An Y, Zhang H Clinics (Sao Paulo). 2023; 78:100298.
PMID: 37897936 PMC: 10630606. DOI: 10.1016/j.clinsp.2023.100298.